Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Zhengxing Powder (正醒散) is a traditional herbal medicine developed by Guizhou Miaoyao Pharmaceutical, rooted in the principles of traditional Miao medicine (Miaoyao). It is formulated as a powder and is intended for the treatment of a diverse range of chronic and systemic conditions, including gout, hypertension, hair loss, lung cancer, and diabetes. The therapeutic rationale for the product is based on traditional Chinese and Miao medicine theories, specifically focusing on the regulation of qi and blood to restore physiological balance. As a traditional remedy, it does not have a defined molecular mechanism of action or specific pharmacological targets in modern clinical terms, and it is typically categorized within the company's pipeline of traditional ethnic medicines.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Zhengxing Powder.